Salidroside Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease via AMPK-Dependent TXNIP/NLRP3 Pathway. The gene discussed is TXNIP; the disease is metabolic dysfunction-associated steatotic liver disease.